168 related articles for article (PubMed ID: 3236417)
21. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
22. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
23. Burkitt's lymphoma in a 45-year-old Nigerian woman.
Lawal OO; Ojo OS; Durosinmi MA
Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442
[TBL] [Abstract][Full Text] [Related]
24. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
[TBL] [Abstract][Full Text] [Related]
25. The effects of rituximab treatment during pregnancy on a neonate.
Friedrichs B; Tiemann M; Salwender H; Verpoort K; Wenger MK; Schmitz N
Haematologica; 2006 Oct; 91(10):1426-7. PubMed ID: 16963391
[TBL] [Abstract][Full Text] [Related]
26. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
27. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
28. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
[TBL] [Abstract][Full Text] [Related]
29. Toothache, paresthesia, and Horner syndrome: an unusual presentation of disseminated Burkitt's lymphoma.
Nissenbaum M; Kaban LB; Troulis MJ
J Oral Maxillofac Surg; 2007 Jul; 65(7):1395-401. PubMed ID: 17577512
[No Abstract] [Full Text] [Related]
30. Primary non-Hodgkin lymphoma of the kidney.
Büchi G; Ganio L; Negro C; Veglio M; Revigliono G; Termine G
Pathologica; 1992; 84(1091):393-6. PubMed ID: 1465324
[No Abstract] [Full Text] [Related]
31. Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.
Kaiser U; Uebelacker I; Havemann K
Leuk Lymphoma; 1999 Dec; 36(1-2):101-8. PubMed ID: 10613454
[TBL] [Abstract][Full Text] [Related]
32. [Intensive treatment of T-cell-rich B lymphoma].
Azaceta G; Palomera L; Varo MJ; Soria J
Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190
[No Abstract] [Full Text] [Related]
33. Burkitt's lymphoma-- what is new?
Abinya ON
East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
[No Abstract] [Full Text] [Related]
34. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Adde M; Shad A; Venzon D; Arndt C; Gootenberg J; Neely J; Nieder M; Owen W; Seibel N; Wilson W; Horak ID; Magrath I
Semin Oncol; 1998 Apr; 25(2 Suppl 4):33-9; discussion 45-8. PubMed ID: 9578060
[TBL] [Abstract][Full Text] [Related]
35. The use of adjuvant chemotherapy for breast cancer in a community practice.
Rosenberg A; Winer EP; Cadman E
Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
[No Abstract] [Full Text] [Related]
36. Case report and review of immunodeficiency-associated Burkitt lymphoma.
Johnson DH; Reske T; Ruiz M
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e121-5. PubMed ID: 25701328
[No Abstract] [Full Text] [Related]
37. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D
Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436
[TBL] [Abstract][Full Text] [Related]
38. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
[TBL] [Abstract][Full Text] [Related]
39. [Ileocolonic invagination in an human immunodeficiency virus-positive man].
Pernas Souto B; López Calvo S; Mena de Cea Á; Pedreira Andrade JD
Gastroenterol Hepatol; 2014; 37(6):359-61. PubMed ID: 24786936
[No Abstract] [Full Text] [Related]
40. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]